Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Biosensors Market, 2022 - Diversity in Applications Propelling Market to Grow Consistently to Reach $25.9 Billion - Research and Markets

Research and Markets
Posted on: 31 Oct 17

The "Biosensors - A Global Market Overview" report has been added to Research and Markets' offering.

Global Biosensors market is expected to record a robust CAGR of about 9% during the 2017-2022 analysis period and is projected to touch US$25.9 billion by 2022 from an estimated US$16.9 billion in 2017.

Electrochemical estimated the largest global Biosensors market by technology with 2017 market stood at US$12 billion while Optical segment is expected the fastest growing Biosensor market worldwide with a CAGR of 10.5% over the same period.

Point of Care Testing is expected to remain the largest application area for Biosensors reaching a projected US$11.5 billion by 2022 growing at a CAGR of 8.1% between 2017 and 2022. In regional markets, Asia Pacific is expected the fastest growing market witnessing a CAGR of 11.4% for the aforementioned period whereas the North American market is estimated the largest end-user for Biosensors.

Key Business Trends

  • Abbott's FreeStyle Libre Glucose Monitoring System Reimbursement in Japan
  • Nanomedical Diagnostics' New NHS Agile Biosensor Chip for Use on Agile R100 Label-free Personal Assay System
  • Abbott and Bigfoot Enter into Collaboration to Develop Diabetes Technologies
  • New NTA Biosensor Chip Launched for use with Label-free Agile R100 Assay System
  • Abbott to Expand its FreeStyle Libre Flash Glucose Monitoring System Coverage in Canada
  • CE Mark for Abbott's TactiCath Contact Force Ablation Catheter
  • Release of Fully Automated Solution for Cell Culture Sampling and Complete Analysis for Bench-Scale Bioreactor Cultures
  • Nanomedical Diagnostics' AGILE R100 Graphene Biosensor Received Patent from USPTO
  • Aerialtronics Joined Forces with RAE Systems BeNeLux for Developing the Altura Zenith ATX8 UAS
  • BD's First Step in the Fight against Antimicrobial Resistance
  • CardioMEMS HF System from Abbott Aid in Heart Failure Hospitalizations
  • Nanomedical Diagnostics and Rogue Valley Microdevices Partnered to Deliver AGILE R100 Graphene Biosensor
  • FLEXcon and Polestar Join Forces
  • Finesse Solutions Acquired by Thermo Fisher Scientific
  • PathSensors and USDA's Agricultural Research Service team to Develop Bio Sensor Technology for Citrus Greening Disease
  • Cepheid Became an Indirect Wholly Owned Subsidiary of Danaher
  • PathSensors, Inc Develops Universal BioSensor Technology
  • PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays
  • Smith Detection Enhances IONSCAN 600 Detector Capabilities
  • MBiotech Acquired by Integrated DNA Technologies
  • Biosensors International Enters into Distribution Agreement with CORDIS
  • BioProfile FLEX2, the Next Addition to the BioProfile Line of Cell Culture Chemistry Analyzers
  • Affymetrix Acquired by Thermo Fisher Scientific
  • LifeScan Launches Onetouch Verio Flex Blood Glucose Monitoring System
  • Animas Vibe Insulation Pump and Continuous Glucose Monitoring System Received FDA Approval for Diabetes Management in Children Ages Two and Older
  • New Drger Tcore Sensor for Non-Invasive and Accurate Measurement of Body's Core Temperature
  • Nanomedical Diagnostics, Inc. Launched to Supply Monitoring and Diagnostic Platforms
  • QIAGEN, the First New Entrant in the US Market for STR Test Kits
  • New Exotic Gas Sensors are Now Available for Honeywell's QRAE 3 Gas Detector
  • LifeScan Launches the New OneTouch Verio Sync Meter

Key Market Trends

  • Technological Advancements in Point-of-Care Testing Further Promotes Growth of Biosensors
  • Glucose Monitoring in Diabetes Worldwide Fueling the Growth of Biosensor Market
  • Growing Emergence of Biosensors in Environmental Application
  • Safety & Bio-Defense - The Emerging Field of Biosensors
  • Optical Biosensors Leads the Growth of Biosensors Industry Driven by Emergence of New Technologies

Key Topics Covered:

Part A: Global Market Perspective

1. Introduction

2. Key Market Trends

3. Biosensors Research & Developments Activities

4. Key Global Players

5. Key Business & Product Trends

6. Global Market Overview

Part B: Regional Market Perspective

Regional Market Overview

1. North America

2. Europe

3. Asia Pacific

4. South America

5. Rest of World

Part C: Guide to the Industry

Part D: Annexure

Companies Mentioned

  • 3M Company
  • ABTECH Scientific, Inc.
  • ACON Laboratories, Inc.
  • Abbott Diabetes Care, Inc.
  • Abbott Laboratories, Inc.
  • Abbott Point of Care, Inc.
  • Acon Laboratories, Inc.
  • Affinity Biosensors, Llc
  • Bayer AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerica, Inc.
  • Biosensor Applications Sweden AB
  • Biosensors International Group, Ltd.
  • Biosensors, Inc.
  • EMD Millipore Corporation
  • Ercon Inc.
  • GE Healthcare Ltd.
  • Medtronic, Inc.
  • Nanomedical Diagnostics, Inc.
  • Neuro-Kinesis Corporation
  • Nova Biomedical Corporation
  • Qiagen N.V.
  • RAE Systems, Inc.
  • Radiometer America, Inc.
  • Roche Diagnostics Corporation
  • SDIX, LLC (formerly Strategic Diagnostics, Inc.)
  • Sensor-Kinesis Corporation
  • Siemens Medical Solutions USA, Inc.
  • Smiths Group Plc
  • Sober Steering Sensors Canada, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Vigene Biosciences, Inc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 31/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.